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Abstract
Purpose: To identify the structural requirements for designing a lead key for insulin-like growth factor (IGF-1R)
inhibition using group-based quantitative structure activity relationship (GQSAR) and molecular docking. Methods:
GQSAR method requires fragmentation of molecules. The molecules in the current dataset were fragmented into
three (R1, R2 and R3) by applying common fragmentation pattern, and fragment-based 2D descriptors were then
calculated. GQSAR models were derived by applying various methods including multiple linear regressions and partial
least square or k-nearest neighbor. Results: Four generated GQSAR models were selected based on the statistical
significance of the model. It was found that the presence of flexible and non-aromatic groups on fragment R1 was
conducive for inhibition. Additionally, the existence of amino groups as hydrogen bond donors at fragments R2 and
R3 was fruitful for inhibition. Docking studies revealed the binding orientation adopted by the active compounds at
several amino acid residues, including Met 1126, Arg, 1128, Met 1052, GLU 1050, Met 1112, Leu 1051, Met 1049, Val
1033, and Val 983 at ATP binding sites of IGF-1R kinase domain. Conclusion: The generated models provide a site-
specific insight into the structural requirements for IGF-1R inhibition which can be used to design and develop potent
inhibitors. © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights
reserved.
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